Existing therapeutic strategies for managing Parkinson disease (PD), which focus on addressing the loss of dopamine and dopaminergic function linked with degeneration of dopaminergic neurons, are limited by side effects and lack of long-term efficacy. In recent decades, research into PD pathophysiology and pharmacology has focused on understanding and tackling the neurodegenerative processes and symptomology of PD. In this Review, we discuss the challenges associated with the development of novel therapies for PD, highlighting emerging agents that aim to target cell death, as well as new targets offering a symptomatic approach to managing features and progression of the disease.
Therapeutic strategies for Parkinson dise... - Cure Parkinson's
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
Did you see my post on the enterovirus evidence of PD? I am trying to gather expert opinion on the quality of that research.
Thanks, Iqbal, a little light reading for the weekend....
Not what you're looking for?
You may also like...
Waking up dormant dopaminergic neurons to reverse Parkinson's disease
Led by Dr. C. Justin Lee along with Dr. Hoon Ryu and Dr. Sang Ryong Jeon, researchers at the Center...
Promising disease modifying therapies for PD
To date, there are no disease-modifying therapies that slow, halt, or reverse the progression of...
Parkinson disease risks: correctly identifying environmental factors for a chronic disease
I can only access the abstract, but it looks significant.
Parkinson disease risks: correctly...
PD drugs accelerate disease progression
quotes
- "All along PD progression brain produces less and less dopamine. Since l-dopa inhibits...
Association Between Antiepileptic Drugs and Incident Parkinson Disease in the UK Biobank
I am unable to post full text article, this is the summary with one comment regarding gabapentin....